the price of "magic weight loss drug" is 15 times higher than other countries! the pricing of "magic weight loss drug" in the united states is questioned
2024-09-26
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
on september 24, local time, lars flülgauer jorgensen, ceo of danish pharmaceutical company novo nordisk, attended a hearing held by the u.s. senate committee on health, education, labor and pensions. the senator questioned the fact that the prices of novo nordisk's diabetes and weight loss drugs in the united states are much higher than those in other countries.
u.s. senator and chairman of the senate health, education, labor and pensions committee bernie sanders said that if novo nordisk's diabetes and weight loss drugs are not priced to make them more affordable, 40,000 people in the united states may die each year. it is understood that millions of americans are currently using novo nordisk's diabetes drug novotec and weight loss drug vigovi.
in response, the ceo of novo nordisk said that the company returned about 75% of drug sales in the form of rebates and discounts, and its drug net prices were far lower than the list price. he also revealed that the company had tried to lower drug prices, but this move was punished by the drug benefit management company, resulting in the loss of the drug market and consumers having no way to buy it. however, the drug benefit management company stated in a statement that they have been committed to reducing the burden on consumers and that the high drug prices are due to novo nordisk's greed.
according to cnn, drug prices in the united states are often several times higher than those in other wealthy countries. the debate over who is responsible for high drug prices often ends up focusing on the pharmaceutical companies that set the prices and the pharmacy benefit management companies that negotiate discounts based on the prices, with both sides often blaming each other.
editor: shen peilan
editor: liu jia
